Flowserve Q4 EPS Beats 18.4%, Raises 2026 Guidance to $4.10
Flowserve’s Q4 sales rose 4.6% to $1.24 billion, missing estimates by 2.5%, while adjusted EPS of $1.11 beat consensus by 18.4% and adjusted EBITDA of $228.3 million surpassed forecasts by 10.5%. The company ends the quarter with a $2.87 billion backlog, expects $4.10 of adjusted EPS in FY2026 (2.6% above estimates), and highlights $100 million in nuclear bookings alongside sustained aftermarket momentum.
1. Q4 Financial Results
Flowserve reported Q4 revenue of $1.24 billion, up 4.6% year-on-year but 2.5% below analyst estimates. Adjusted EPS came in at $1.11, an 18.4% beat, and adjusted EBITDA reached $228.3 million (18.5% margin), 10.5% ahead of forecasts, while operating margin declined to 3.4% from 10.6% a year ago.
2. Aftermarket Strength and Nuclear Expansion
The aftermarket segment delivered its seventh consecutive quarter of bookings above $600 million, offsetting original equipment delays driven by customer and material timing. Flowserve recorded over $100 million in nuclear market bookings and expects the Trillium Valves acquisition to increase content per reactor by 15–20%, underpinning diversified revenue streams.
3. Outlook and Guidance
Management set FY2026 adjusted EPS guidance at $4.10 per share, 2.6% ahead of consensus, supported by a $2.87 billion backlog up 2.8% year-on-year. The company plans to drive margin expansion through the 80/20 portfolio program, operational excellence initiatives and targeted M&A integration, while anticipating gradual backlog conversion into revenue.